Neumora Therapeutics NMRA
NASDAQ NMRA
$0.50 -0.05 (-9.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Sales of Property, Plant and Equipment (2025 - 2026)

Updated

Neumora Therapeutics (NMRA) recorded Sales of Property, Plant and Equipment of $71,000 in Q1 2026, up 51.1% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Sales of Property, Plant and Equipment (2025 - 2026) Analysis & Trends

For FY2025, Neumora Therapeutics reported Sales of Property, Plant and Equipment of $218,000.

  • Quarterly Sales of Property, Plant and Equipment has ranged from $47,000 in Q4 2025 to $87,000 in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $47,000 (Q4 2025), $87,000 (Q3 2025) and $84,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Neumora Therapeutics 93.95 Mn 93.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 71,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 87,000.00
Jun 30, 2025 84,000.00
API Access

Neumora Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=NMRA&period=max&api_key=YOUR_API_KEY